Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-03

Clinical Trial Update: Extended Duration Artemether-lumefantrine Treatment for Malaria in Children [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on extended-duration artemether-lumefantrine treatment for uncomplicated Plasmodium falciparum malaria in children. Results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Uncomplicated Plasmodium Falciparum Malaria | Phase 4 | Status: COMPLETED | Results posted: 2025-01-03